NGS Pharma: Biotech Current Events

Attend this meeting and you will

• Get a master class from the FDA and hear how their initiative on advancing regulatory science is impacting emerging technologies and next-generation sequencing projects
• Explore the bioinformatic approaches that the Sanger Institute, European Bioinformatics Institute and GSK are adopting to digest huge data sets and extract meaningful, manageable information for optimised research efforts and drug development programmes
• Hear overviews of the metagenomics tactics that Nestlé and the Institut Scientifique de Recherche Agronomique are employing to understand the role of the microbiome in the discovery and development of drugs for metabolic diseases
• Discover the ‘multi-omics’ systems biology strategies utilised by GSK and Janssen for patient stratification to provide insights into the mechanisms of response or relapse to therapy
• Learn about the efforts Janssen, GSK and UCL are taking to apply high-throughput genomics technologies and data integration for optimised biomarker discovery and target validation
• Hear Novartis, AstraZeneca and QMUL explain how the latest innovations in NGS are being applied to RNA-seq for gene expression profiling as a replacement for microarray

Bringing together pharma, biotechs, research institutes and leading technology and solution providers, this meeting will provide an unbeatable, unmissable opportunity. Share best practices, learn from the leaders and come together to discuss the best methods to harness the potential of next generation sequencing technologies to support research efforts, reduce drug development costs and improve the performance of your pipeline.

Expect open and lively discussion, great networking opportunities, new solutions to seemingly impossible challenges, and a raft of groundbreaking ideas to take back to your organisation and transform your research and business opportunities.

(Courtesy of http://www.nextgeneration-sequencing.com/)

NGS Pharma - EuroBioForum